CVC Infection (SUDAN)
Transcription
CVC Infection (SUDAN)
Management of Catheter-Related Bloodstream infections (CRBSI) Nabil Abouchala, MD, FACP, FCCP Consultant, Pulmonary & ICU King Faisal hospital and Research Center It is what we think we know already that often prevents us from learning. --Claude Bernard Hospital course 64 YM with previous complicated history Gastric outlet obstruction secondary to gastric neoplasm. TPN due to malnutrition and inability to feed orally June 8, 2010 at of 04:00: Hypotension, tachycardia and tachypnea Hospital course June 8, 2010 at of 04:00: Hypotension BP 77/50, tachycardia and tachypnea Assessment: Dehydration versus sepsis versus cardiac causes. Blood cultures were obtained. No antibiotic was administered. 2 boluses of IV fluid The patient BP picked up to 105/70 Cardiology at 5:30 AM: ST-T changes unchanged from baseline. Hospital course At 9:30 a.m. Patient developed cardiopulmonary arrest with asystole 25 minutes of CPR after which he had return of spontaneous circulation. Transferred to the ICU Working diagnosis Severe shock Septic vs. cardiogenic Admission KFSH- MSICU Mechanical ventilation, new central line in the right IJ, the PICC line was removed and cultured. Patient was started on inotropic support using high dose Levophed, phenylephrine, and dopamine. The patient had severe refractory shock with maximum systolic pressure of 70, anuria, lactic acidosis (10), DIC. Empiric antibiotic were started in ICU, using imipenem, vancomycin and Flagyl which were administered at 10:30 a.m. Patient died from refractory shock at 17:50 Septic shock 4:00 AM CPR 9:30 AM Antibiotic 10:30 AM Death 5:50 PM Blood Culture Do Central Lines Cause Bloodstream Infections? Maki DG. Infections due to infusion therapy. In: Hospital Infections, Third Edition, Bennett JV, Brachman PS (eds), Little, Brown, Boston 1992. Incidence and Risk 48% of ICU patients have CVCs, accounting for 15 million CVC-days per year in ICUs. The case fatality rate for catheter-related bloodstream infections approaches …20% Between 500-4,000 U.S. patients die annually due to bloodstream infections Cost per infection $3,700 to $29,000. BSIs prolong hospitalization by a mean of 7 days. Mermel LA. Ann Int Med. 2000;132: 391-402. Soufir L et al. Infect Control Hosp Epidemiol. 1999 Jun;20(6):396-401. CR sepsis with blood culture Probable CR sepsis Catheter contamination Catheter colonization Independent Risk Factors for CLBSI Prolonged hospitalization Duration of catheterization Site of catheterization Femoral Neutropenia TPN Colonization at the insertion site of the catheter hub Substandard care of the catheter: excessive manipulation reduced nurse-topatient ratio Infection control and hospital epidemiology; October 2008 GPC Fungi GNR Micro organisms responsible for CR-BSI according to catheter site 45% 40% 17% Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines Hand Hygiene O’Grady NP. MMWR. Aug 9, 2002; 51: RR10, 1-29. Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines Maximal Barrier Precautions (MBP) • For the Provider: – Hand hygiene – Non-sterile cap and mask • All hair should be under cap • Mask should cover nose and mouth tightly – Sterile gown and gloves • For the Patient: – Cover patient’s head and body with a large sterile drape Why Not MBP? More cumbersome Time-consuming More expensive Supplies and not always readily available Impact of Maximal Barrier Precautions (MBR) Author/date Design Catheter Odds Ratio for infection w/o MBR Mermel 1991 Prospective Swan Ganz Cross-sectional 2.2 (p<0.03) Raad 1994 Prospective Randomized 6.3 (p<0.03) Central OR=odds ratio MBR= inserter washes hands and wears mask, sterile gown, sterile gloves and patient’s head & body are covered with a large, sterile drape. Mermel LA, Am J Med. Sep 16 1991;91(3B):197S-205S. Raad, Infect Control Hosp Epidemiol. Apr 1994;15(4 Pt 1):231-238. MBP: Cost analysis • Additional cost $40 – Additional material cost $15 – Additional time needed 20 minutes for $25 • • • • Decrease BSI 5.3% 2.8% Catheter colonization 5.5% 2.9% Death from 0.8% 0.4% Use of MBP lowered cost – $621 $369 = $250 Compliance 30% Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines Chlorhexidine Skin Antisepsis Chlorhexidine Skin Antisepsis Povidence Iodine Chlorhexidine Lowers BSI 50% Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines CDC Recommendation Regarding Site Selection O’Grady NP. MMWR. Aug 9, 2002; 51: RR10, 6. What About SC vs. IJ vs. Femoral? • N= 2018 patients – SC – IJ – Femoral 917 1390 288 What About SC vs. IJ vs. Femoral? • CRLI• CRBSI – any signs of local inflammation + catheter tip > 15 CFU CRLI + positive blood cultures Distribution of Internal Jugular Vein According to Quadrant Reade M et al. N Engl J Med 2007;357:943-945 US-guided placement vs. landmark technique for insertion of IJ CVC Outcome measures in the ultrasound group versus the landmark group of patients Outcome measures Ultrasound group (n = 450) Landmark group (n = 450) Access time (seconds) 17.1 ± 16.5 44 ± 95.4 Success rate 450 (100%)a 425 (94.4%) 5 (1.1%)a 48 (10.6%) 2 (0.4%)a 38 (8.4%) 0 (0%) 11 (2.4%) 1.1 ± 0.6 (1.1 to 1.9)a 2.6 ± 2.9 (1.5 to 6.3) 47 (10.4%)a 72 (16%) Carotid puncture Hematoma Pneumothorax Average number of attempts CVC-BSI Karakitsos et al. Critical Care 2006 10:R162 Summary • IJ site: – low rate of severe mechanical complications – preferred for short-term access < 7 days • SC site: – lower risk of infection – route of choice, in experienced hands, if for long-term access > 7 days • Femoral site: – higher rate of infections and thrombosis – should be restricted to patients in whom the mechanical complications of SC access, i.e. pneumothorax or hemorrhage would be unacceptable Central Line Bundle Elements 1. 2. 3. 4. Hand hygiene Maximal barrier precautions Chlorhexidine skin antisepsis Optimal catheter site selection, with subclavian vein as the preferred site for non-tunneled catheters in adults 5. Daily review of line necessity with prompt removal of unnecessary lines Do You Still Need a CVC? If Not Remove It! What Else Reduces CVC infections? Dressing impregnated with CHD Needle connector system Scrubbing the hub Chlorhexidine Impregnated Dressing Scrub the HUB! American Journal Infection Control 2008 Recommendation for Implementing Prevention and Monitoring Strategies Before insertion At insertion After insertion • Education • Indications, appropriate insertions and maintenance • Complete an educational program • Credentialing process • Catheter checklists • Hand hygiene • Avoid using femoral vein • Subclavian site if no increased risk • Use all-inclusive catheter cart • Use MBP • Use chlorhexidine antiseptic • Disinfect catheter hubs • Remove nonessential catheters • Change transparent dressing every 5 -7 days Infection control and hospital epidemiology; October 200 Special Approach for the Prevention of CLBSI Units/patient population BSI > Goal Patients with limited venous access Patient with high-risk for sequelae BSI Use of antibioticcoated catheters Chlorhexidinecontaining dressing Antimicrobial locks for CVCs Infection control and hospital epidemiology; October 200 “If you don’t prevent You will create an event”
Similar documents
Global Market Study on Peripheral Intravenous Catheter Market, 2015-2021
The global peripheral intravenous catheter market was valued at US$ 3,500 Mn in 2014. North America was the largest market for peripheral intravenous catheters, accounting for over 45% revenue share of the overall market in 2014, followed by Europe with around 27% share. Moreover, Asia-Pacific market is expected to exhibit highest CAGR of 6.7% during the forecast period (2015–2021), followed by the North America. Factors such as increasing per capita healthcare spending, increasing aging population, increase in a number of diseases, and advancement in PIVC technology are expected to support a growth of the peripheral intravenous catheter market over the forecast period.
More information